Stanford University: Mood Disorders trials
The registry lists 11 Mood Disorders studies with Stanford University as lead sponsor. 2 are open to participants now and 3 have results posted.
Phase 3 1Phase 4 2No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical SettingsRecruitingNCT07155707Not applicable
- Light and Sleep FragmentationNot yet recruitingNCT06009289Phase 4
- Pioglitazone in Patients With Mood DisordersCompletedNCT01559857Phase 4Results posted
- Functional MRI Before and After Treatment for DepressionTerminatedNCT00896441Not applicableResults posted
- Treatment of Psychotic Major Depression With MifepristoneTerminatedNCT00867360Phase 3Results posted
- Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical SettingsCompletedNCT06364137Not applicable
- Peripheral Immune System in Individuals With SchizophreniaCompletedNCT05109065
- Precision Psychiatry Continuity Clinic ProjectCompletedNCT03260985Not applicable
- Research on Anxiety and Depression: Computer-Assisted TherapyCompletedNCT02817438Not applicable
- Insulin Resistance in Patients With Major DepressionCompletedNCT01106313
- Side Effects of Antipsychotic MedicationsCompletedNCT00363181